Table 1 Baseline diseases of patients in the study.

From: A novel cytotherapy device for rapid screening, enriching and combining mesenchymal stem cells into a biomaterial for promoting bone regeneration

Diseases

Number and percentage of patients

Nonunion

20 (47.6%)

Fresh fractureψ

11 (26.2%)

Others

 

Bone defect after hardware removal

2 (4.8)

Ankle arthrodesis revision

3 (7.1%)

Benign bone tumor

3 (7.1%)

Delayed union

2 (4.8)

Ankle deformity

1 (2.4%)

  1. ψA fresh fracture was defined as a fracture that occurred no earlier than 2 weeks before the surgical treatment.
Back to article page